z-logo
Premium
Mulberroside A suppresses PXR‐mediated transactivation and gene expression of P‐gp in LS174T cells
Author(s) -
Li Yuhua,
Huang Ling,
Sun Jiahong,
Wei Xiaohua,
Wen Jinhua,
Zhong Guoping,
Huang Min,
Bi Huichang
Publication year - 2017
Publication title -
journal of biochemical and molecular toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.526
H-Index - 58
eISSN - 1099-0461
pISSN - 1095-6670
DOI - 10.1002/jbt.21884
Subject(s) - transactivation , pregnane x receptor , chemistry , gene expression , gene , microbiology and biotechnology , biology , transcription factor , biochemistry , nuclear receptor
Mulberroside A (Mul A) is the main bioactive constituents of Sangbaipi, which is officially listed in the Chinese Pharmacopoeia. The pregnane X receptor (PXR) has been recognized as the critical mediator of human P‐glycoprotein (P‐gp) gene transactivation. In this study, the effect of Mul A on PXR‐mediated transactivation and gene expression of P‐gp was investigated. It was found that Mul A significantly suppressed PXR‐mediated P‐gp luciferase activity induced by rifampicin (Rif). Furthermore, Rif induced an elevation of P‐gp expression and transport activity, which was apparently suppressed by Mul A. However, Mul A did not suppress the P‐gp luciferase activity, P‐gp expression, and function in the absence of Rif. These findings suggest that Mul A suppresses PXR‐mediated transactivation and P‐gp expression induced by Rif. This should be taken into consideration to predict any potential herb–drug interactions when Mul A or Sangbaipi are co‐administered with Rif or other PXR agonist drugs.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom